Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care

  • First published: 09 September 2021
  • Last modified: 09 September 2021
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
The NHS Commissioning Board (operating under the name of NHS England)
Authority ID:
AA73994
Publication date:
09 September 2021
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

The NHS Commissioning Board (operating under the name of NHS England)

2nd Floor, Rutland House

Runcorn

WA7 2ES

UK

Contact person: Philip Grieve

E-mail: philip.grieve@nhs.net

NUTS: UK

Internet address(es)

Main address: https://www.england.nhs.uk/

Address of the buyer profile: https://www.england.nhs.uk/

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.4) Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care

Reference number: CM/PHS/20/5623

II.1.2) Main CPV code

33651660

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care. Period of framework agreement: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months . Please refer to the invitation to offer documents for a list of the purchasing points.

II.1.6) Information about lots

This contract is divided into lots: Yes

II.1.7) Total value of the procurement

Value excluding VAT: 68 184 420.00  GBP

II.2) Description

Lot No: 1

II.2.1) Title

Lot 1 - aQIV

II.2.2) Additional CPV code(s)

33651660

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)

II.2.4) Description of the procurement

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 10%

Quality criterion: Ease of Use / Weighting: 3%

Price / Weighting:  87%

II.2.11) Information about options

Options: Yes

Description of options:

option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 2

II.2.1) Title

Lot 2 - QIV-HD

II.2.2) Additional CPV code(s)

33651660

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)

II.2.4) Description of the procurement

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 10%

Quality criterion: Ease of Use / Weighting: 3%

Price / Weighting:  87%

II.2.11) Information about options

Options: Yes

Description of options:

option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 3

II.2.1) Title

Lot 3 - QIVc

II.2.2) Additional CPV code(s)

33651660

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)

II.2.4) Description of the procurement

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 10%

Quality criterion: Ease of Use / Weighting: 3%

Price / Weighting:  87%

II.2.11) Information about options

Options: Yes

Description of options:

option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 4

II.2.1) Title

Lot 4 - QIVr

II.2.2) Additional CPV code(s)

33651660

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)

II.2.4) Description of the procurement

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 10%

Quality criterion: Ease of Use / Weighting: 3%

Price / Weighting:  87%

II.2.11) Information about options

Options: Yes

Description of options:

option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 5

II.2.1) Title

Lot 5 - QIVe

II.2.2) Additional CPV code(s)

33651660

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)

II.2.4) Description of the procurement

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

II.2.5) Award criteria

Quality criterion: Security of Supply / Weighting: 10%

Quality criterion: Ease of Use / Weighting: 3%

Price / Weighting:  87%

II.2.11) Information about options

Options: Yes

Description of options:

option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2021/S 000-009004

Section V: Award of contract

A contract/lot is awarded: No

V.1 Information on non-award

The contract/lot is not awarded

No tenders or requests to participate were received or all were rejected

Section V: Award of contract

Lot No: 1

Contract No: CM/PHS/20/5623

Title: aQIV

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

18/08/2021

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Seqirus UK Limited

Point, 29 Market Street

Maidenhead

SL6 8AA

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: Lowest offer: 1.00  GBP / Highest offer: 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 3

Contract No: CM/PHS/20/5623

Title: QIVc

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

18/08/2021

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Seqirus UK Limited

Point, 29 Market Street

Maidenhead

SL6 8AA

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: Lowest offer: 1.00  GBP / Highest offer: 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 4

Contract No: CM/PHS/20/5623

Title: QIVr

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

18/08/2021

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Aventis Pharma ltd t/a Sanofi

410 Thames Valley, Park Drive, Reading

Reading

RG6 1PT

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: Lowest offer: 1.00  GBP / Highest offer: 1.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 5

Contract No: CM/PHS/20/5623

Title: QIVe

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

18/08/2021

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Aventis Pharma ltd t/a Sanofi

410 Thames Valley, Park Drive, Reading

Reading

RG6 1PT

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: Lowest offer: 1.00  GBP / Highest offer: 1.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.4) Procedures for review

VI.4.1) Review body

The High Court

Strand

London

WC2A 2LL

UK

E-mail: generaloffice@administrativecourtoffice.justice.gov.uk

Internet address(es)

URL: https://www.gov.uk/courts-tribunals

VI.5) Date of dispatch of this notice

08/09/2021

Coding

Commodity categories

ID Title Parent category
33651660 Influenza vaccines General anti-infectives for systemic use and vaccines

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
philip.grieve@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.